nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Carboplatin—uterine cancer	0.147	0.252	CbGbCtD
Levetiracetam—ABCC2—Etoposide—uterine cancer	0.123	0.212	CbGbCtD
Levetiracetam—ABCB1—Progesterone—uterine cancer	0.0898	0.154	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—uterine cancer	0.0841	0.144	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—uterine cancer	0.0712	0.122	CbGbCtD
Levetiracetam—ABCB1—Etoposide—uterine cancer	0.0402	0.069	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—uterine cancer	0.0274	0.047	CbGbCtD
Levetiracetam—SV2A—myometrium—uterine cancer	0.0146	0.172	CbGeAlD
Levetiracetam—SV2A—uterine cervix—uterine cancer	0.0113	0.134	CbGeAlD
Levetiracetam—SV2A—endometrium—uterine cancer	0.0103	0.121	CbGeAlD
Levetiracetam—SV2A—mammalian vulva—uterine cancer	0.00993	0.117	CbGeAlD
Levetiracetam—SV2A—female gonad—uterine cancer	0.00774	0.0912	CbGeAlD
Levetiracetam—SV2A—vagina—uterine cancer	0.00769	0.0907	CbGeAlD
Levetiracetam—SV2A—lymph node—uterine cancer	0.00497	0.0587	CbGeAlD
Levetiracetam—CACNA1B—lymph node—uterine cancer	0.00344	0.0405	CbGeAlD
Levetiracetam—ABCC2—renal system—uterine cancer	0.00238	0.028	CbGeAlD
Levetiracetam—ABCC2—female reproductive system—uterine cancer	0.0019	0.0224	CbGeAlD
Levetiracetam—ABCB1—myometrium—uterine cancer	0.00117	0.0138	CbGeAlD
Levetiracetam—ABCC2—lymph node—uterine cancer	0.00111	0.0131	CbGeAlD
Levetiracetam—ABCB1—epithelium—uterine cancer	0.000921	0.0109	CbGeAlD
Levetiracetam—ABCB1—uterine cervix—uterine cancer	0.000914	0.0108	CbGeAlD
Levetiracetam—ABCB1—decidua—uterine cancer	0.00087	0.0103	CbGeAlD
Levetiracetam—ABCB1—renal system—uterine cancer	0.000855	0.0101	CbGeAlD
Levetiracetam—ABCB1—endometrium—uterine cancer	0.000826	0.00974	CbGeAlD
Levetiracetam—ABCB1—mammalian vulva—uterine cancer	0.000799	0.00942	CbGeAlD
Levetiracetam—ABCB1—uterus—uterine cancer	0.000761	0.00898	CbGeAlD
Levetiracetam—ABCB1—female reproductive system—uterine cancer	0.000684	0.00807	CbGeAlD
Levetiracetam—ABCB1—female gonad—uterine cancer	0.000623	0.00734	CbGeAlD
Levetiracetam—ABCB1—vagina—uterine cancer	0.000619	0.0073	CbGeAlD
Levetiracetam—ABCB1—lymph node—uterine cancer	0.0004	0.00472	CbGeAlD
Levetiracetam—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000351	0.00105	CcSEcCtD
Levetiracetam—Eczema—Epirubicin—uterine cancer	0.00035	0.00105	CcSEcCtD
Levetiracetam—Hepatic failure—Epirubicin—uterine cancer	0.00035	0.00105	CcSEcCtD
Levetiracetam—Mediastinal disorder—Etoposide—uterine cancer	0.00035	0.00105	CcSEcCtD
Levetiracetam—Mental disability—Doxorubicin—uterine cancer	0.000348	0.00105	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000347	0.00104	CcSEcCtD
Levetiracetam—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000346	0.00104	CcSEcCtD
Levetiracetam—Alopecia—Etoposide—uterine cancer	0.000343	0.00103	CcSEcCtD
Levetiracetam—Vomiting—Progesterone—uterine cancer	0.000343	0.00103	CcSEcCtD
Levetiracetam—Rash—Progesterone—uterine cancer	0.00034	0.00102	CcSEcCtD
Levetiracetam—Dermatitis—Progesterone—uterine cancer	0.00034	0.00102	CcSEcCtD
Levetiracetam—Headache—Progesterone—uterine cancer	0.000338	0.00102	CcSEcCtD
Levetiracetam—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00101	CcSEcCtD
Levetiracetam—Decreased appetite—Dactinomycin—uterine cancer	0.000331	0.000997	CcSEcCtD
Levetiracetam—Renal impairment—Epirubicin—uterine cancer	0.000331	0.000994	CcSEcCtD
Levetiracetam—Dermatitis bullous—Epirubicin—uterine cancer	0.000329	0.00099	CcSEcCtD
Levetiracetam—Fatigue—Dactinomycin—uterine cancer	0.000329	0.000989	CcSEcCtD
Levetiracetam—Back pain—Etoposide—uterine cancer	0.000327	0.000984	CcSEcCtD
Levetiracetam—Pain—Dactinomycin—uterine cancer	0.000326	0.00098	CcSEcCtD
Levetiracetam—Eczema—Doxorubicin—uterine cancer	0.000324	0.000974	CcSEcCtD
Levetiracetam—Hepatic failure—Doxorubicin—uterine cancer	0.000324	0.000974	CcSEcCtD
Levetiracetam—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000323	0.000972	CcSEcCtD
Levetiracetam—Lethargy—Epirubicin—uterine cancer	0.000321	0.000966	CcSEcCtD
Levetiracetam—Nausea—Progesterone—uterine cancer	0.00032	0.000964	CcSEcCtD
Levetiracetam—Hyponatraemia—Epirubicin—uterine cancer	0.000316	0.00095	CcSEcCtD
Levetiracetam—Diplopia—Epirubicin—uterine cancer	0.000315	0.000946	CcSEcCtD
Levetiracetam—Feeling abnormal—Dactinomycin—uterine cancer	0.000314	0.000945	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000312	0.000938	CcSEcCtD
Levetiracetam—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.000935	CcSEcCtD
Levetiracetam—Affect lability—Epirubicin—uterine cancer	0.00031	0.000932	CcSEcCtD
Levetiracetam—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000308	0.000927	CcSEcCtD
Levetiracetam—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000308	0.000926	CcSEcCtD
Levetiracetam—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000306	0.000921	CcSEcCtD
Levetiracetam—Renal impairment—Doxorubicin—uterine cancer	0.000306	0.00092	CcSEcCtD
Levetiracetam—Dermatitis bullous—Doxorubicin—uterine cancer	0.000305	0.000916	CcSEcCtD
Levetiracetam—Face oedema—Epirubicin—uterine cancer	0.000304	0.000914	CcSEcCtD
Levetiracetam—Vertigo—Etoposide—uterine cancer	0.000304	0.000914	CcSEcCtD
Levetiracetam—Leukopenia—Etoposide—uterine cancer	0.000303	0.00091	CcSEcCtD
Levetiracetam—Abdominal pain—Dactinomycin—uterine cancer	0.000301	0.000906	CcSEcCtD
Levetiracetam—Body temperature increased—Dactinomycin—uterine cancer	0.000301	0.000906	CcSEcCtD
Levetiracetam—Mood swings—Epirubicin—uterine cancer	0.000298	0.000897	CcSEcCtD
Levetiracetam—Lethargy—Doxorubicin—uterine cancer	0.000297	0.000894	CcSEcCtD
Levetiracetam—Ataxia—Epirubicin—uterine cancer	0.000296	0.00089	CcSEcCtD
Levetiracetam—Cough—Etoposide—uterine cancer	0.000295	0.000887	CcSEcCtD
Levetiracetam—Convulsion—Etoposide—uterine cancer	0.000293	0.000881	CcSEcCtD
Levetiracetam—Dehydration—Epirubicin—uterine cancer	0.000293	0.00088	CcSEcCtD
Levetiracetam—Hyponatraemia—Doxorubicin—uterine cancer	0.000292	0.000879	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—uterine cancer	0.000291	0.000876	CcSEcCtD
Levetiracetam—Liver function test abnormal—Epirubicin—uterine cancer	0.00029	0.000874	CcSEcCtD
Levetiracetam—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00029	0.000873	CcSEcCtD
Levetiracetam—Chest pain—Etoposide—uterine cancer	0.000288	0.000866	CcSEcCtD
Levetiracetam—Abdominal pain upper—Epirubicin—uterine cancer	0.000287	0.000864	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—uterine cancer	0.000287	0.000862	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000286	0.00086	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000283	0.000852	CcSEcCtD
Levetiracetam—Nasopharyngitis—Epirubicin—uterine cancer	0.000281	0.000846	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—uterine cancer	0.000281	0.000845	CcSEcCtD
Levetiracetam—Hypersensitivity—Dactinomycin—uterine cancer	0.000281	0.000845	CcSEcCtD
Levetiracetam—Confusional state—Etoposide—uterine cancer	0.000278	0.000837	CcSEcCtD
Levetiracetam—Muscular weakness—Epirubicin—uterine cancer	0.000278	0.000835	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—uterine cancer	0.000276	0.00083	CcSEcCtD
Levetiracetam—Infection—Etoposide—uterine cancer	0.000274	0.000824	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—uterine cancer	0.000274	0.000823	CcSEcCtD
Levetiracetam—Asthenia—Dactinomycin—uterine cancer	0.000273	0.000823	CcSEcCtD
Levetiracetam—Influenza—Epirubicin—uterine cancer	0.000272	0.000818	CcSEcCtD
Levetiracetam—Asthma—Epirubicin—uterine cancer	0.000272	0.000818	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—uterine cancer	0.000271	0.000814	CcSEcCtD
Levetiracetam—Thrombocytopenia—Etoposide—uterine cancer	0.00027	0.000813	CcSEcCtD
Levetiracetam—Eosinophilia—Epirubicin—uterine cancer	0.000269	0.00081	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—uterine cancer	0.000269	0.000808	CcSEcCtD
Levetiracetam—Skin disorder—Etoposide—uterine cancer	0.000268	0.000806	CcSEcCtD
Levetiracetam—Pancreatitis—Epirubicin—uterine cancer	0.000267	0.000802	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—uterine cancer	0.000266	0.0008	CcSEcCtD
Levetiracetam—Anorexia—Etoposide—uterine cancer	0.000263	0.000791	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000262	0.000789	CcSEcCtD
Levetiracetam—Bronchitis—Epirubicin—uterine cancer	0.000262	0.000787	CcSEcCtD
Levetiracetam—Diarrhoea—Dactinomycin—uterine cancer	0.000261	0.000785	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—uterine cancer	0.00026	0.000783	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—uterine cancer	0.000258	0.000777	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—uterine cancer	0.000257	0.000772	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—uterine cancer	0.000254	0.000765	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000253	0.00076	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—uterine cancer	0.000252	0.000757	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—uterine cancer	0.000252	0.000757	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—uterine cancer	0.000249	0.000749	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—uterine cancer	0.000248	0.000745	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—uterine cancer	0.000247	0.000744	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—uterine cancer	0.000247	0.000742	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—uterine cancer	0.000246	0.00074	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—uterine cancer	0.000245	0.000738	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—uterine cancer	0.000242	0.000729	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—uterine cancer	0.000242	0.000729	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—uterine cancer	0.000242	0.000729	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—uterine cancer	0.000242	0.000729	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—uterine cancer	0.000242	0.000728	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00024	0.000723	CcSEcCtD
Levetiracetam—Rash—Dactinomycin—uterine cancer	0.00024	0.000723	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—uterine cancer	0.00024	0.000721	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—uterine cancer	0.000239	0.000719	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—uterine cancer	0.000238	0.000716	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—uterine cancer	0.000238	0.000715	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—uterine cancer	0.000236	0.000711	CcSEcCtD
Levetiracetam—Constipation—Etoposide—uterine cancer	0.000236	0.00071	CcSEcCtD
Levetiracetam—Pain—Etoposide—uterine cancer	0.000236	0.00071	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—uterine cancer	0.000236	0.000709	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—uterine cancer	0.000236	0.000709	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—uterine cancer	0.000235	0.000708	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000234	0.000703	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—uterine cancer	0.000229	0.00069	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—uterine cancer	0.000229	0.000689	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—uterine cancer	0.000229	0.000688	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—uterine cancer	0.000228	0.000685	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—uterine cancer	0.000227	0.000684	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—uterine cancer	0.000227	0.000684	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—uterine cancer	0.000226	0.000681	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—uterine cancer	0.000226	0.000681	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—uterine cancer	0.000226	0.000679	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—uterine cancer	0.000224	0.000675	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—uterine cancer	0.000224	0.000675	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—uterine cancer	0.000224	0.000675	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000222	0.000669	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—uterine cancer	0.000219	0.000658	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—uterine cancer	0.000218	0.000656	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—uterine cancer	0.000218	0.000656	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—uterine cancer	0.000218	0.000656	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—uterine cancer	0.000218	0.000656	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—uterine cancer	0.000218	0.000656	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—uterine cancer	0.000218	0.000655	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—uterine cancer	0.000216	0.00065	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—uterine cancer	0.000214	0.000643	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000212	0.000638	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—uterine cancer	0.000212	0.000637	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—uterine cancer	0.00021	0.000633	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—uterine cancer	0.000209	0.00063	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—uterine cancer	0.000206	0.000619	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—uterine cancer	0.000203	0.000612	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—uterine cancer	0.000203	0.000611	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—uterine cancer	0.000202	0.000607	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—uterine cancer	0.000201	0.000606	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—uterine cancer	0.0002	0.000601	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—uterine cancer	0.000198	0.000595	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—uterine cancer	0.000198	0.000595	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—uterine cancer	0.000197	0.000591	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—uterine cancer	0.000196	0.00059	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—uterine cancer	0.000195	0.000587	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—uterine cancer	0.000192	0.000579	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—uterine cancer	0.000191	0.000574	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—uterine cancer	0.00019	0.000573	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—uterine cancer	0.000189	0.00057	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—uterine cancer	0.000189	0.000568	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—uterine cancer	0.000188	0.000566	CcSEcCtD
Levetiracetam—Tension—Epirubicin—uterine cancer	0.000186	0.000559	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—uterine cancer	0.000184	0.000554	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—uterine cancer	0.000183	0.000551	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—uterine cancer	0.000182	0.000549	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—uterine cancer	0.000182	0.000547	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—uterine cancer	0.000182	0.000546	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—uterine cancer	0.000179	0.000537	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—uterine cancer	0.000178	0.000535	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—uterine cancer	0.000176	0.000531	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—uterine cancer	0.000175	0.000528	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—uterine cancer	0.000175	0.000527	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—uterine cancer	0.000174	0.000524	CcSEcCtD
Levetiracetam—Rash—Etoposide—uterine cancer	0.000174	0.000523	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—uterine cancer	0.000174	0.000523	CcSEcCtD
Levetiracetam—Headache—Etoposide—uterine cancer	0.000173	0.00052	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—uterine cancer	0.000172	0.000518	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—uterine cancer	0.00017	0.000512	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—uterine cancer	0.00017	0.000512	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—uterine cancer	0.00017	0.00051	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—uterine cancer	0.00017	0.00051	CcSEcCtD
Levetiracetam—Cough—Epirubicin—uterine cancer	0.000165	0.000497	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—uterine cancer	0.000165	0.000497	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—uterine cancer	0.000164	0.000494	CcSEcCtD
Levetiracetam—Nausea—Etoposide—uterine cancer	0.000164	0.000493	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—uterine cancer	0.000161	0.000485	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—uterine cancer	0.000161	0.000485	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—uterine cancer	0.000161	0.000485	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—uterine cancer	0.000161	0.000485	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—uterine cancer	0.000161	0.000484	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00016	0.000482	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—uterine cancer	0.000158	0.000474	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—uterine cancer	0.000157	0.000472	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—uterine cancer	0.000156	0.000469	CcSEcCtD
Levetiracetam—Infection—Epirubicin—uterine cancer	0.000154	0.000462	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—uterine cancer	0.000153	0.00046	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—uterine cancer	0.000152	0.000457	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—uterine cancer	0.000152	0.000456	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—uterine cancer	0.000151	0.000455	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—uterine cancer	0.00015	0.000452	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—uterine cancer	0.000149	0.000449	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—uterine cancer	0.000149	0.000449	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—uterine cancer	0.000149	0.000449	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—uterine cancer	0.000149	0.000447	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000148	0.000446	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—uterine cancer	0.000147	0.000443	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—uterine cancer	0.000144	0.000434	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—uterine cancer	0.000142	0.000428	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000141	0.000424	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—uterine cancer	0.00014	0.000422	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—uterine cancer	0.00014	0.000421	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—uterine cancer	0.00014	0.000421	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—uterine cancer	0.000139	0.000418	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—uterine cancer	0.000139	0.000418	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—uterine cancer	0.000137	0.000414	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—uterine cancer	0.000136	0.00041	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—uterine cancer	0.000136	0.000409	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—uterine cancer	0.000134	0.000404	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000134	0.000402	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—uterine cancer	0.000133	0.000401	CcSEcCtD
Levetiracetam—Pain—Epirubicin—uterine cancer	0.000132	0.000398	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—uterine cancer	0.000132	0.000398	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00013	0.000392	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—uterine cancer	0.000129	0.000389	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—uterine cancer	0.000128	0.000386	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—uterine cancer	0.000127	0.000383	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—uterine cancer	0.000127	0.000383	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—uterine cancer	0.000126	0.00038	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—uterine cancer	0.000126	0.000379	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—uterine cancer	0.000124	0.000374	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000124	0.000372	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—uterine cancer	0.000123	0.000371	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—uterine cancer	0.000122	0.000368	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—uterine cancer	0.000122	0.000368	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—uterine cancer	0.000122	0.000368	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—uterine cancer	0.000122	0.000368	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—uterine cancer	0.000118	0.000355	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000117	0.000352	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—uterine cancer	0.000114	0.000343	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—uterine cancer	0.000113	0.00034	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—uterine cancer	0.000113	0.00034	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—uterine cancer	0.000111	0.000334	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—uterine cancer	0.000109	0.000329	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—uterine cancer	0.000106	0.000318	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—uterine cancer	0.000105	0.000317	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—uterine cancer	0.000103	0.000309	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—uterine cancer	0.000102	0.000308	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—uterine cancer	0.000101	0.000305	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—uterine cancer	9.83e-05	0.000296	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—uterine cancer	9.79e-05	0.000294	CcSEcCtD
Levetiracetam—Rash—Epirubicin—uterine cancer	9.75e-05	0.000293	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—uterine cancer	9.74e-05	0.000293	CcSEcCtD
Levetiracetam—Headache—Epirubicin—uterine cancer	9.69e-05	0.000291	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—uterine cancer	9.46e-05	0.000285	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—uterine cancer	9.19e-05	0.000276	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—uterine cancer	9.1e-05	0.000274	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—uterine cancer	9.02e-05	0.000271	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—uterine cancer	9.01e-05	0.000271	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—uterine cancer	8.96e-05	0.00027	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—uterine cancer	8.5e-05	0.000256	CcSEcCtD
